[newsclippings/dhmh_header.htm]
Visitors to Date

Office of Public Relations

 
 
 
DHMH Daily News Clippings
Thursday, January 8, 2009

 

Ailing Economy Afflicts Clinic (Washington Post)
 

 
 
WJLA-TV
Wednesday, January 7, 2009
 
POOLESVILLE, Md. - Neighbors say a dreaded disease is popping up more and more in their Montgomery County community.
 
Poolesville residents Fred and Betsy Kelly have their hands full with their two-month-old daughter Helena Lucia and a life-shattering cancer diagnosis.
 
Right after her daughter was born, doctors removed Betsy Kelly's kidney -- the five-pound tumor on it weighed more than the newborn. Kelly has since lost part of her arm and has tumors in her lungs.
 
"It's a very aggressive cancer, it's very rare in people my age," Kelly explained. "I have no family history of kidney cancer at all," she added. "So that's our concern: what has caused it?"
 
Kelly is one of five women, including her next-door neighbor, living on Hempstone Avenue to get cancer. Now, residents are saying it seems to be too much of a coincidence.
 
"The people that we've seen and heard of, especially I've talked to my neighbors, have been mostly women, in their late 30s and early 40s, to have gotten cancers," Fred Kelly said.
 
The Kellys suspect the water in their town may be the culprit. Almost all of Poolesville, a community of 5,000, relies on town wells.
 
Town officials insist the wells pass state and federal regulations. "We are consistently safe in all our analysis that are returned to us that MDE and EPA take, so yes, it is safe to drink by their standards," said Poolesville town manager Wade Yost.
 
Health officials cite many possible sources of carcinogens. Nearby Dickerson, in fact, is home to an incinerator, coal-burning power plant and a nuclear facility -- a potential Superfund site.
 
That all is little consolation to the Kellys, who now only drink bottled water and hope they will all be OK.
 
© 2009 WJLA-TV.

 
County studies high number of cancer cases in community
 
WTOP-TV
Wednesday, January 7, 2009
 
POOLESVILLE, Md. -- Montgomery County is studying a high number of cancer cases in the Poolesville community, the Gazette reported.
 
Residents believe the reason could be in the water.
 
One resident alerted the Montgomery County Department of Health after his pregnant wife, who has no family history of cancer, was diagnosed with renal cancer in October.
 
Their neighbor, a 15-year resident of Poolesville who also has no family history of cancer and who doesn't drink or smoke, was diagnosed with a cancer that affects the salivary glands two years ago. Another woman on the street was diagnosed with the same rare form of cancer 14 years ago, the Gazette reported.
 
Some residents wonder whether a trash incinerator, a nuclear facility or a coal-burning power plant is to blame, but there is also concern about Poolesville's water supply, samples from which have tested for high -- but necessarily above federal limits -- levels of radionuclide particles, which the EPA said can cause cancer in large doses over a long period of time.
 
© NBC Universal, Inc.

 
 
Baltimore Sun Letter to the Editor
Thursday, January 8, 2009
 
A recent letter regarding the Keswick Multi-Care Center's proposal for the Baltimore Country Club property misrepresents the zoning aspects of the proposal ("Roland Park proposal imperils zoning code," Jan. 5).
 
Keswick's plan for its continuing-care community would require the City Council to approve a planned unit development (PUD) ordinance for the property but would not require the area's existing R-1 zoning to be changed.
 
The R-1 zoning category was not designed as an exclusive single-family enclave but, in fact, expressly permits such nonresidential uses as schools, museums, community recreation centers and religious institutions.
 
It further allows such conditional uses as nonprofit clubs, hospitals, nursing and elderly care facilities, swimming pools and residential planned unit developments.
 
Indeed, the Roland Park area already has four successful planned unit developments, including Roland Park North, which is in an R-1 district, Roland Park Place and the mixed-use Village of Cross Keys, which is across the street from the land Keswick proposes to develop.
 
The planned unit development provision was an important feature of the city's last comprehensive zoning code, which was adopted in 1971.
 
More than 100 of them have been adopted since then, and they have proved successful in all areas of the city when communities and developers have worked together.
 
The mayor was correct in urging Roland Park to work with Keswick and come up with the best plan for both parties.
 
Alfred W. Barry III
Baltimore
 
The writer is a former assistant director of planning for the city of Baltimore who is now a planning consultant for the Keswick Multi-Care Center.
 
Copyright 2008 Baltimore Sun.

 
 
By Ceci Connolly
Washington Post
Thursday, January 8, 2009; A01
 
The pharmaceutical industry, confronting sluggish growth, low prestige and the prospect of more-aggressive government oversight, is moving on several fronts to burnish its image and align itself rhetorically with the health reform goals of President-elect Barack Obama and the Democratic Congress.
 
Conceding that it has long been viewed as Republican-dominated, the industry's lobbying arm plans to spend tens of millions of dollars on an advertising blitz promoting Obama-style health coverage for every American. The first spot -- sponsored by the drug lobby, consumer and labor groups, and health providers -- will be unveiled today.
 
Beginning this month, drug companies also will voluntarily submit to a host of marketing restrictions in an attempt to preempt stricter regulations that lawmakers in both parties are pursuing.
 
"We had better self-police and stop doing the things that cause so much criticism, or we're going to get legislated and regulated by government," said W.J. "Billy" Tauzin, the Republican former congressman who runs the Pharmaceutical Research and Manufacturers of America (PhRMA), a trade association. The changes, he said in an interview, are an effort to move away from the industry's "slash-and-burn kind of policy" in response to previous regulatory and legislative efforts.
 
Even before Obama's victory, the drug lobby took a dramatic political turn: In 2008, for the first time in 18 years, industry contributions to Democrats were on par with money given to Republicans, according to an analysis by the Center for Responsive Politics, a watchdog group.
 
"PhRMA had been isolated into a one-party camp," Tauzin said. "We're trying to reposition as less of a partisan player."
 
The maneuvering comes at a time of great stress for America's drugmakers, which have not been enthusiastic proponents of past health-care reform efforts. After double-digit growth throughout the 1990s and much of this decade, the pharmaceutical industry is expected to grow less than 2 percent in 2009, according to the independent research firm IMS Health. Analysts say it will be difficult to improve on that in the next few years, given the weak economy and a dwindling supply of new blockbuster medications coming to market.
 
Equally worrisome to many in the business is the arrival of a Democratic president who, in tandem with a Democratic-controlled Congress, is expected to add muscle to the Food and Drug Administration and press for an overhaul of the U.S. health system.
 
Some individual companies are moving independently, suggesting strains in the once-unified drug lobby. In mid-December, Merck announced that it was joining a coalition in support of broad health-care reform, including controversial measures to compare the performance and price of medications.
 
"We understand clearly that we are entering this debate at a time when the pharmaceutical industry's standing is low," Kenneth Frazier, president of Merck's Global Human Health unit, said in a speech. "We face a choice of acting from a place of fear of the potential harms that could occur to us in reform or acting on the hope of what reform could mean to our industry."
 
On the immediate horizon are two proposed regulatory changes that would dramatically alter how the industry markets its products.
 
Sen. Charles E. Grassley (R-Iowa) intends to refile a bill requiring drug and biotech companies to report to the federal government all gifts or payments to physicians for research, speeches, travel, consulting or anything else. Companies failing to report would face financial penalties. The bill is in response to lavish industry spending, which critics maintain creates conflicts of interest for doctors.
 
Rep. Henry A. Waxman (D-Calif.), the incoming chairman of the Energy and Commerce Committee, supports legislation giving the FDA power to selectively ban direct-to-consumer advertising in the initial years a medication is on the market.
 
"It is in these first few years of a drug's life that drug companies often aggressively market their products," Waxman said in a recent speech. "This increases the number of consumers exposed to safety risks of new products, long before those risks are truly understood."
 
The drug industry supported a watered-down version of the Grassley bill and has opposed giving the FDA power over ads directed at patients. Instead, PhRMA members have adopted a voluntary marketing code.
 
As of the start of this year, about 40 companies agreed to stop distributing notepads, pens, T-shirts, soap dispensers, napkins and other tchotchkes festooned with product logos. Drugmakers describe the gifts as "reminder items" for doctors and nurses who may forget what cholesterol pill or diabetes medication they want to prescribe. But many consumers suspect that the goodies, as well as more extravagant gifts such as travel and meals, lead to medical decisions that have less to do with sound science than with clever marketing.
 
The voluntary code, which encourages but does not require companies to hire an independent auditor to monitor their compliance, also sets new restrictions on buying meals for physicians. Fancy restaurant dinners are out unless they include a substantive presentation from a medical expert. Food deliveries to a physician's office are still acceptable, as are some meals at conferences.
 
In 2005, the industry spent more than $6.8 billion on the goodies, meals and other office visits, according to a report in the New England Journal of Medicine.
 
Patient advocacy groups say the voluntary changes will fall short of altering the cozy relationship between doctors and pharmaceutical companies.
 
"I'm not sure it actually changes the number of meals the industry is providing all that much," said Allan Coukell, policy director of the Prescription Project, a Boston-based nonprofit that often finds itself pitted against drugmakers.
 
In March, drug companies will also begin following stricter advertising policies. Actors posing as doctors, as well as celebrity endorsers such as artificial-heart inventor Robert Jarvik, will be identified accurately in commercials. Suggestive ads for products such as the impotence drugs Viagra and Cialis will be pulled from day time slots when children are likely to be watching. And ads will contain information on programs designed to help patients understand and afford the medications.
 
"You're seeing a greater trend toward transparency and openness among pharmaceutical companies to let people know how we do business and what services are available," said AstraZeneca spokesman Tony Jewell. AstraZeneca's spots conclude with a plug for the company's prescription savings program, information that Jewell says helps patients.
 
Tauzin defended direct advertising as a means to not only educate patients about treatments but also alert them to illnesses they may not realize they have. Even so, he recognized the "perception problem" of the ads, a problem he characterized as "you're smoking in bed and the house is on fire."
 
In a speech last month, Roche Pharmaceuticals chief executive William Burns hinted that the Swiss company may go further than the PhRMA guidelines.
 
"Direct-to-consumer promotion was the single worst decision for the industry," he said. "When industry says, 'We're spending all the money on [research and development],' but actually it's spending it on DTC advertising to preserve margins, it doesn't get much credibility."
 
Grassley and consumer watchdog groups say they are far more troubled by sizable industry payments to doctors for activities often labeled as consulting, research or continuing medical education. In addition, they note that the PhRMA guidelines have no enforcement mechanism.
 
"People are less apt to violate a federal law than a code of ethics of its own profession," Grassley said. He also said companies making biotech drugs, including a number of very expensive new treatments for cancer and other diseases, should not be exempt. So far, the trade group BIO -- the Biotechnology Industry Organization -- has refused to adopt even the PhRMA code.
 
The industry's voluntary efforts are "a start, not an end," Grassley said in an interview. "You can't say it's a substitute for what I'm trying to do."
 
Copyright 2008 Washington Post.

 
Provider of HIV-AIDS Programs Cuts Its Staff, Sells Buildings to Survive
 
By Timothy Wilson
Washington Post
Thursday, January 8, 2009; DZ01
 
Moving day had arrived last month for the Whitman-Walker Clinic at 1407 S St. NW. For more than 20 years, the location had been an enclave for clients, volunteers and staff members in the effort to fight the spread of HIV-AIDS in the District.
 
Times had been rough recently, prompting the building's sale and a move to consolidated quarters around the corner, at 14th and R streets, to get out from under a mountain of debt.
 
But just when staff members thought they had reached bottom, the situation got worse.
 
The day after the move, the clinic announced that it would be forced to outsource some programs, close a clinic in Arlington County and lay off up to 45 of its 178 employees by the end of March.
 
"Clearly, this is a difficult situation for us," Donald Blanchon, Whitman-Walker chief executive officer, said in a statement. "The current state of the economy has forced us to make tough decisions."
 
The decisions have included abruptly laying off 15 veteran staff members without severance Dec. 19, four days after the S Street location was closed.
 
Whitman-Walker, which began life as a health center for gay men and grew into a nationally recognized provider of programs for people with HIV-AIDS, has been struggling with declining revenue and increased expenses because of an increase in patient care for most of a decade. But the faltering economy has made the clinic scale back even further.
 
"The clinic is not immune to anything that is going on," Blanchon said in an interview. "The days of Whitman-Walker Clinic being all things to all people is probably not practical now."
 
This recent round of layoffs will reduce staffing at the clinic by 25 percent. In 2005, the clinic had about 260 employees. By March, that number will have been reduced by almost half, Blanchon said.
 
Until she was let go, Patricia Hawkins was an associate executive director at the clinic.
 
On the Friday before Christmas, Hawkins said, a procession of employees entered Blanchon's office one at a time to learn their fates. Mary Bahr, a former director of administration and grant writer, was let go first. The last, Barbara Chinn, a former director of the Max Robinson Clinic in Southeast, would follow hours later.
 
"I had to keep back a tear or two as some of the clients said goodbye," said Chinn, who began working at the clinic in 1987. "I felt like I had walked out on a portion of my life. It was a little unnerving."
 
Chinn and Hawkins, who began volunteering at the clinic in 1984, had experienced some turbulent years there.
 
In 1997, about 25,000 people participated in the clinic's annual AIDS Walk. The event was the largest fundraiser for the clinic and netted $1.7 million that year. Five years later, only 7,000 people participated, and the event netted about $100,000. In 2003, the clinic began charging for some of its services to offset declining donations and rising costs.
 
By 2005, Whitman-Walker had reached a point where it couldn't meet its payroll one week. It swung into retrenchment mode.
 
It sold a group home in Northern Virginia and a facility housing a clinic in Maryland. It discontinued programs for substance abusers, a food bank and affordable housing. As it consolidated and ended programs, it laid off staff members. It began selling more of its buildings across the region. The S Street property was the latest to go, in the fall, and to some it looked like a solution was in sight.
 
"I thought that once we got the [S Street] building sold, we'd be stable," Hawkins said.
 
But solid ground remained elusive.
 
Blanchon said the building sale helped to resolve only some past financial problems, and that other measures were necessary to deal with an influx of new patients.
 
He said the layoffs would reduce the number of administrative and management positions at the clinic and would allow them to focus on providing high-quality health care to the patients who visit on a daily basis.
 
But with steep declines in government funding, private donations and staffing, the clinic faces significant challenges in providing primary medical care to people living with HIV-AIDS.
 
According to the District's Department of Health, the number of new HIV-AIDS cases and deaths has declined annually from 2002 to 2006, but the number of people living with HIV-AIDS has increased by almost 50 percent during that time. That increase has led more people with HIV to the doors of the Whitman-Walker Clinic.
 
"We need more doctors, dentists, psychotherapists and addiction counselors," Blanchon said. "Every one of our employees now understands the challenges we are facing. The quality of what we do matters."
 
Chinn said the staff members who remain are extremely responsive to the needs of the gay, lesbian, bisexual and transgender community and will provide excellent care. She said she hopes the lack of resources won't compromise the message of HIV-AIDS awareness.
 
"I only hope the clinic can quickly get itself on solid ground," Chinn said. "I hope this last cut is the last that the clinic has to make in terms of staffing. Maybe it can see its way toward rebuilding. It'd be a shame for the community to lose the Whitman-Walker Clinic."
 
Copyright 2008 Washington Post.

 
 
By Rosalind S. Helderman and Nelson Hernandez
Washington Post
Thursday, January 8, 2009; PG03
 
Prince George's County health authorities have quietly moved toward a solution to what was once one of the public school system's most alarming problems: the large number of students who were being barred from school because they had not received state-mandated vaccinations.
 
John White, spokesman for the Prince George's school system, said a campaign to get kids to clinics for their chickenpox and hepatitis B shots had reduced the number of students who lacked immunizations from more than 2,300 a year ago to 268 as of mid-December, before the winter break.
 
School officials celebrated the decline then, saying they hoped to take care of the remaining few over the break and this month.
 
"It's amazing," said Betty Despenza-Green, the school system's chief of student services, who credited the decline to "a lot of pressure" and "nurses being very, very strategic" in their targeting of students who needed the vaccinations. There was a change in the attitude of parents and students as well.
 
"People didn't think we were taking this seriously and therefore they didn't comply," said Karen Bates, the school system's health services supervisor. "Now they think we are taking this seriously."
 
The public snapped to attention in November 2007, when R. Owen Johnson Jr. (District 5), then chairman of the school board, called the issue an "educational crisis" and State's Attorney Glenn F. Ivey (D) said he would prosecute parents who allowed their children to remain out of compliance, offenses that carry fines of $50 a day or up to 10 days in jail.
 
In practice, the court did not throw people in jail over the immunizations, but the legal threat briefly gained national news coverage and helped persuade parents in the county to cooperate, school officials said.
 
"I think certainly that contributed to it," Bates said of the turnaround. "It served to send a message that everyone in the county was connected and collaborative around this issue of immunization. . . . This [school] year we haven't even had to talk about taking those kinds of measures. I think every year it's going to become easier and easier."
 
Copyright 2008 Washington Post.

 
 
By Jane Gross
New York Times
Thursday, January 8, 2009
 
Hardly anyone has a good word to say about this country’s fragmented system for delivering and paying for long-term care, with one exception: the P.A.C.E. program, which many experts laud as long-term care done right.
 
P.A.C.E., an acronym for “program of all-inclusive care for the elderly,” provides anything and everything a frail elderly person and her family might need, coordinated by a team of medical and social service providers, for an annual fee generally paid by Medicare and Medicaid. The care can be delivered at home, a P.A.C.E. center, a hospital or a long-term care facility — seamlessly moving back and forth under the supervision of one interdisciplinary team for a fixed cost.
 
The model for P.A.C.E. was developed 27 years ago in San Francisco’s Chinatown/North Beach area by a community center called On Lok (Cantonese for “peaceful, happy abode”). The On Lok approach was replicated elsewhere using foundation grants and gradually embraced by Congress, which eventually authorized all P.A.C.E. programs as Medicare providers.
 
The formula is hard to quarrel with. According to several studies, P.A.C.E. clients, while far more frail than the average Medicare recipient, cost taxpayers less money in government-funded medical care, have fewer and shorter hospital stays, rarely wind up in nursing homes (even though they must be eligible to enroll in one), and report satisfaction rates close to 100 percent.
 
Readers of this blog, physicians, researchers in geriatrics and gerontology, clients and family members — all have urged that I visit to a P.A.C.E. center, and so recently I did.
 
The nation’s largest P.A.C.E. provider is the Comprehensive Care Management Corporation in the Bronx. What I found there is a model that bridges the customary divide between acute and chronic care, and assigns each client to an interdisciplinary team that coordinates care across different settings. The program pays for coverage as a H.M.O. would, with a fixed annual cost per patient rather than a fee-for-service set-up.
 
But unlike many H.M.O.’s, the program doesn’t operate as a faceless bureaucracy serving as gatekeeper to all but primary care physicians, and granting and denying services or procedures. Rather, at 40-odd locations in 22 states, P.A.C.E. means care by an interdisciplinary team that knows the patient and family, their histories, strengths, limitations and goals. Team members decide the care plan with each member, tweak it as things change, and rarely say ‘no’ to anything that will sustain quality of life.
 
P.A.C.E. offers its members access to primary care physicians, specialists, home health aides, transportation, recreation and companionship at a day center, meals (at the center or delivered to home), medical assistance on call 24-hours-a-day — and just about anything else that will make it possible for extremely frail and cognitively impaired elders to remain at home.
 
The breadth and flexibility of P.A.C.E.’s services were apparent during a daily team meeting in late December, on the eve of a snow storm. First the assembled doctors, nurses, social workers, rehabilitation and recreation specialists, transportation coordinators, clinic schedulers and office managers reviewed the overnight emergency calls. These had been answered by a real person who had assessed whether a trip to the emergency room was needed or the problem could be handled by phone or with a home visit, always the goal. One person hospitalized overnight because of seizures had already received a dawn visit from her regular P.A.C.E. doctor, with reassurance that her home health aide was on standby for her return and that her missing coat had been located.
 
The team then discussed new clients and those needing changes in their care plan: a woman who felt well enough to come to the center five days a week and thus required a new transportation schedule; a hospitalized patient ready for discharge whom they hoped to keep to keep longer, since his wife needed a break from caregiving; a new member who’d asked for more fresh fruits and vegetables among the daily lunch choices.
 
Next came a review of everyone who had been expected that day at the center on Allerton Avenue — one of seven run by C.C.M. in the New York metropolitan area — but had not shown up yet. Some were out of town visiting relatives, others at outside medical appointments or under the weather. A few had been stranded by transportation glitches. Anyone unaccounted for — and there were only a few — would be called or visited immediately, especially with the storm bearing down.
 
All P.A.C.E. members are ranked by priority. Level 1 means they can’t be alone at home without an aide. Level 2 means they need someone to shop, organize medications or otherwise make a short home visit every day. And level 3 means they are either safe alone or have family or neighbors for back-up support. Since weather reports suggested the center might have only a skeleton staff the next day, arrangements were made to get aides, food, backup oxygen tanks and whatever was needed to each of 300 clients classified at levels 1 or 2. For level 3 clients, staff would doublecheck that relatives and friends hadn’t all decamped for the holidays.
 
Outside the meeting room, three staff physicians were seeing patients. On certain days, they are joined by a wound care expert, since pressure sores are an abiding problem for those who spend all their time in bed or in a wheelchair. Also available are two psychiatrists specializing in depression, anxiety and dementia-related agitation; an opthalmologist and optometrist to treat the myriad of vision problems associated with age; and a podiatrist, because many older people cannot cut their own toenails and risk infection or diabetic complications if the job is not done regularly and carefully.
 
Other specialists, on contract from a local hospital, see patients in their own offices, with transportation and translation provided by P.A.C.E., as well as immediate consultation between the primary care doctor and the specialist.
 
In the recreation and dining areas, members are welcome for breakfast and lunch and sent home with dinner. At the Allerton Ave. center, located in an area with a large Latino population, someone reads newspapers aloud in Spanish every day, down to the horoscopes and the box scores.
 
Staff members take notice if anyone is making frequent trips to the bathroom, and a nurse is on hand to check for a urinary tract infection, another condition especially dangerous for the elderly. The center has handicapped-accessible showers for those who can’t use the ones they have at home, as well as washing machines and dryers. Some clients manage but one visit a week; others come daily. All are provided free transport, with an aide if necessary, but also have the option of many of the same services at home.
 
All P.A.C.E. members nationwide must be 55 or older and eligible under state regulations for nursing home placement, which generally means they require assistance or supervision with basic tasks like bathing, dressing, walking or getting from bed to a wheelchair. Medicare, which provides health coverage for all Americans over the age of 65, pays a share of the “capitated” annual free per member. Medicaid pays the remainder for those who qualify on grounds of low income.
 
Anyone otherwise eligible for P.A.C.E. but not covered by Medicaid can make up the difference out-of-pocket, which in New York State would be around $3,500 a month — a tidy sum but far less than the cost of home health aides, assisted living with the enhanced services people this frail would need, or placement in a skilled nursing facility. In other words, this excellent care is not limited to the indigent, as it is in many other pilot programs run by Medicaid.
 
Each P.A.C.E. program must manage its funds wisely, lest the cost of services exceeds the fixed fees. That encourages preventive care that members might not receive otherwise. For instance, government reimbursement and most private insurance will not pay for ongoing physical therapy once a patient has “plateaued,” and so often treatment stops, which can lead to further loss of mobility. But since physical therapy is cheaper than repairing a broken hip or providing round-the-clock care for someone who is bed-bound, P.A.C.E. does pay for ongoing physical therapy, an approach that is cost-effective to the taxpayer, according to several studies, and leads to better outcomes.
 
After a day at the P.A.C.E. center, my only reservation is whether a middle-class person — say, my mother — would have given a program like this a chance or been put off by the race, ethnicity or cultural differences of the other clients. She was by no means a prejudiced woman, but the older she got the more her comfort level depended on being among people of similar background.
 
I was embarrassed to raise this question. But, P.A.C.E. officials told me, my mother’s resistance would not have been unusual or viewed as a sign of bad character. Shared experience matters at this time of life, and P.A.C.E. centers tend to reflect the neighborhoods where they are located. My mother might have done well at C.C.M.’s Westchester County center, in White Plains, N.Y., or a center in Amityville on Long Island that is soon to open.
 
P.A.C.E. centers around the country are listed on the Web site of the National P.A.C.E. Association, along with program details. Further information is available through the Centers for Medicare & Medicaid Services. My thanks to all of you who told me to go take a look.
 
Copyright 2008 New York Times.

 
 
By Sara Michael
Baltimore Examiner
Thursday, January 8, 2008
 
Research by Greater Baltimore Medical Center clinicians has prompted changes in delivery room practices that could help many low-weight babies avoid lung disease.
 
Babies weighing less than 5.5 pounds can suffer from chronic lung disease, which can lead to long hospital stays, frequent readmission to the hospital and a risk of neurodevelopmental delays.
 
Dr. Howard Birenbaum, GBMC's director of neonatology, and other researchers studied practices that would reduce chronic lung disease cases. The findings were reported in this month's edition of the journal Pediatrics.
 
The changes include avoiding endotracheal intubation in the delivery room and using continuous positive airway pressure machines in the delivery room to help the babies breathe.
 
Birenbaum noticed an increase in the incidence of chronic lung disease between 1997 and 2002, and in 2003, implemented this initiative. By 2005, lung disease cases decreased to 20.5 percent, down from 46.5 percent in 2002.
 
Copyright 2008 Baltimore Examiner.

 
 
By Donald G. McNeil Jr.
New York Times
Thursday, January 8, 2009
 
Virtually all the flu in the United States this season is resistant to the leading antiviral drug Tamiflu, and scientists and health officials are trying to figure out why.
 
The problem is not yet a public health crisis because this is a below-average flu season so far and the chief strain circulating is still susceptible to other drugs — but infectious disease specialists are nonetheless worried.
 
Last winter, about 11 percent of the throat swabs from patients with the most common type of flu that were sent to the Centers for Disease Control and Prevention for genetic typing showed a Tamiflu-resistant strain. This season, 99 percent do.
 
“It’s quite shocking,” said Dr. Kent A. Sepkowitz, director of infection control at the Memorial Sloan-Kettering Cancer Center. “We’ve never lost an antibiotic this fast. It blew me away.”
 
The single mutation that creates Tamiflu resistance appears to be spontaneous, and not a reaction to overuse of the drug. It may have occurred in Asia, and it was widespread in Europe last year.
 
In response, the C.D.C. issued new guidelines two weeks ago. They urged doctors to test suspected flu cases as quickly as possible to see if they are influenza A or influenza B and then, if they are A, whether they are H1 or H3 viruses.
 
The only Tamiflu-resistant strain is an H1N1. Its resistance mutation could fade out, a C.D.C. scientist said, or a different flu strain could overtake H1N1 in importance, but right now it causes almost all flu cases in the country, except in a few mountain states, where H3N2 is prevalent.
 
Complicating the problem, antiviral drugs work only if they are taken within 48 hours. A patient with severe flu could be given the wrong drug and die of pneumonia before test results come in. So the new guidelines suggest that doctors check with their state health departments to see which strains are most common locally and treat for them.
 
“We’re a fancy hospital and we can’t even do the A versus B test in a timely fashion,” Dr. Sepkowitz said. “I have no idea what a doctor in an unfancy office without that lab backup can do.”
 
If a Tamiflu-resistant strain is suspected, the disease control agency suggests using Relenza. But it is harder to take — it is a powder that must be inhaled and can cause lung spasms, and it is not recommended for children under age 7.
 
Relenza, made by GlaxoSmithKline, is known generically as zanamivir. Tamiflu, made by Roche, is known generically as oseltamivir.
 
Alternatively, patients who have trouble inhaling Relenza can take a mixture of Tamiflu and rimantadine, an older generic drug that the agency stopped recommending two years ago because so many flu strains were resistant to it. By chance, the new Tamiflu-resistant H1N1 strain is not.
 
“The bottom line is that we should have more antiviral drugs,” said Dr. Arnold S. Monto, a flu expert at the University of Michigan’s School of Public Health. “And we should be looking into multidrug combinations.”
 
New York City had tested only two flu samples as of Jan. 6, and both were Tamiflu-resistant, said Dr. Annie Fine, an epidemiologist at the city’s health department. Flu cases in the city are only “here and there,” she said, and there have been no outbreaks in nursing homes. Elderly patients, and those with the AIDS virus or on cancer therapy are most at risk.
 
But, she added, because of the resistance problem, the city is speeding up its laboratory procedures so it can do both crucial tests within one day.
 
“And we strongly suggest that people get a flu shot,” she said. “There’s plenty of time and plenty of vaccine.” Exactly how the Tamiflu-resistant strain emerged is a mystery, several experts said.
 
Resistance appeared several years ago in Japan, which uses more Tamiflu than any other country, and experts feared it would spread.
 
But the Japanese strains were found only in patients already treated with Tamiflu, and they were “weak” — that is, they did not transmit to other people.
 
“This looks like a spontaneous development of resistance in the most unlikely places — possibly in Norway, which doesn’t use antivirals at all,” Dr. Monto said.
 
Dr. Henry L. Niman, a biochemist in Pittsburgh who runs recombinomics.com, a Web site tracking the genetics of flu cases around the world, has been warning for months that Tamiflu resistance in H1N1 was spreading.
 
He argues that it started in China, where Tamiflu use is rare, then was seen last year in Norway, France and Russia, then moved to South Africa, where winter is June to September, and then back to the northern hemisphere in November.
 
The mutation conferring resistance to Tamiflu, known in the shorthand of genetics as H274Y on the N gene, was actually, he said “just a passenger, totally unrelated to Tamiflu usage, but hitchhiking on another change.”
 
The other mutation, he said, known as A193T on the H gene, made the virus better at infecting people.
 
Furthermore, he blamed mismatched flu vaccines for helping the A193T mutation spread. Flu vaccines typically protect against three flu strains, but none have contained protections against the A193T mutation.
 
Dr. Joseph S. Bresee, the C.D.C.’s chief of flu prevention, said he thought Dr. Niman was “probably right” about the resistance having innocently piggy-backed on a mutation on the H gene — which creates the spike on the outside of the virus that lets it break into human cells. But he doubted that last year’s flu vaccine was to blame, since the H1 strain in it protected “not perfectly, but relatively well” against H1N1 infection, he said.
 
Dr. Niman said he worried about two aspects of the new resistance to Tamiflu. Preliminary data out of Norway, he said, suggested that the new strain was more likely to cause pneumonia.
 
Flu typically kills about 36,000 Americans a year, the C.D.C. estimates, most of them elderly, very young or with problems like asthma or heart disease, and pneumonia is usually the fatal complication.
 
And while seasonal flu is relatively mild, the Tamiflu resistance could transfer onto H5N1 bird flu circulating in Asia and Egypt, which has killed millions of birds and about 250 people since 2003. Although H5N1 has not turned into a pandemic strain, as many experts recently feared it would, it still could — and Tamiflu resistance in that case would be a disaster.
 
Copyright 2008 New York Times.

 
Bacteria on doctor uniforms can kill you.
 
By Betsy McCaughey
Wall Street Journal Commentary
Thursday, January 8, 2008
 
You see them everywhere -- nurses, doctors and medical technicians in scrubs or lab coats. They shop in them, take buses and trains in them, go to restaurants in them, and wear them home. What you can't see on these garments are the bacteria that could kill you.
 
Dirty scrubs spread bacteria to patients in the hospital and allow hospital superbugs to escape into public places such as restaurants. Some hospitals now prohibit wearing scrubs outside the building, partly in response to the rapid increase in an infection called "C. diff." A national hospital survey released last November warns that Clostridium difficile (C. diff) infections are sickening nearly half a million people a year in the U.S., more than six times previous estimates.
 
The problem is that some medical personnel wear the same unlaundered uniforms to work day after day. They start their shift already carrying germs such as C.diff, drug-resistant enterococcus or staphylococcus. Doctors' lab coats are probably the dirtiest. At the University of Maryland, 65% of medical personnel confess they change their lab coat less than once a week, though they know it's contaminated. Fifteen percent admit they change it less than once a month. Superbugs such as staph can live on these polyester coats for up to 56 days.
 
Do unclean uniforms endanger patients? Absolutely. Health-care workers habitually touch their own uniforms. Studies confirm that the more bacteria found on surfaces touched often by doctors and nurses, the higher the risk that these bacteria will be carried to the patient and cause infection.
 
Until about 20 years ago, nearly all hospitals laundered scrubs for their staff. A few hospitals are returning to that policy. St. Mary's Health Center in St. Louis, Mo., reduced infections after cesarean births by more than 50% by giving all caregivers hospital-laundered scrubs, as well as requiring them to wear two layers of gloves. Monroe Hospital in Bloomington, Ind., which has a near-zero rate of hospital-acquired infections, provides laundered scrubs for all staff and prohibits them from wearing scrubs outside the building. Stamford Hospital in Connecticut recently banned wearing scrubs outside the hospital.
 
Across the pond, a British study found that one-third of medical personnel did not launder their uniforms before coming to work. One British surgeon who specializes in hip and knee replacements reduced postoperative infections by two-thirds at her hospital by protecting patients from contaminated uniforms. Before approaching any patient's bed, nurses put on disposable, clear plastic aprons that were pulled off rolls like dry cleaning bags. Each one costs a nickel.
 
In response to this evidence and public outrage over infections, the cash-strapped British National Health Service is providing nurses with hospital-laundered "smart scrubs." The smart design includes short sleeves, because long sleeves spread germs from patient to patient.
 
The new British policy will protect patients and prevent superbugs from being carried outside hospitals. In one study, more than 20% of nurses' uniforms had C. diff on them at the end of a shift. The germ can cause extreme diarrhea, dehydration, inflammation of the colon, and even death.
 
In a hospital, C. diff contaminates virtually every surface. It spreads when traces of an infected person's feces get in another person's mouth. Patients who touch objects in their room and then eat without washing their hands unknowingly swallow the germ. Many otherwise healthy patients who go into the hospital for elective surgery, such as hip replacement, have contracted C. diff and died.
 
Outside the hospital, C. diff is also difficult to control. It isn't killed by laundry detergents or most cleaners. Researchers at Case Western Reserve and the Cleveland Veterans Administration Medical Center found that even after routine cleaning, 78% of surfaces still had C. diff. Only scrubbing with bleach removed it. That's not the kind of cleaning restaurants are prepared to do after serving hospital workers.
 
Imagine sliding into a restaurant booth after a nurse has left the germ on the table or seat. You could easily pick it up on your hands and then swallow it with your sandwich. Hospitals should provide workers with clean uniforms and prohibit wearing them in public.
 
Ms. McCaughey, former lieutenant governor of New York state, is a fellow at the Hudson Institute and chair of the Committee to Reduce Infection Deaths.
 
Copyright 2008 Dow Jones & Company, Inc. All Rights Reserved.

BACK TO TOP

 

 
 
 

[newsclippings/dhmh_footer.htm]